Britannia Completes “Go Public” Transaction via Reverse Takeover of Rise Life Sciences and Launches Britannia Life Sciences Inc.
TORONTO, Nov. 15, 2021 /CNW/ – Britannia Life Sciences Inc. (BLAB: CSE) (“Britannia”) is pleased to announce the successful completion of its “go public” transaction by way of a reverse take-over (the “RTO”) of RISE Life Science Corp. (“RISE”) (formerly RLSC: CSE). The RTO constituted a “fundamental change” of RISE pursuant to the policies of the Canadian Securities Exchange (the “CSE”). In this news release, references to “Resulting Issuer” or “Britannia” are to RISE after the closing of the RTO. It is anticipated that the common shares of Britannia (“BLAB Shares”) will begin trading on the CSE by the end of this week under the symbol “BLAB”.
In connection with the RTO, RISE has changed its name to “Britannia Life Sciences Inc.” Britannia is a profitable global product development platform offering diversified product testing, quality assurance, consumer safety and regulatory compliance services to a broad range of cosmetic, consumer goods and wellness companies, The Company has a specialized expertise in the formulation and regulation around cannabinoid based edible and topical products.
Peter Shippen, Chief Executive Officer and Director of Britannia commented: “I’d like to thank our employees, investors, advisors and stakeholders for their support through this important milestone. We have an ambitious growth strategy to increase the scale of our operations through sustained high organic growth and accretive acquisitions.”